Literature DB >> 1438145

Changes in atrial natriuretic factor and plasma renin activity in dogs infected with Trypanosoma brucei.

J M Ndung'u1, N G Wright, F W Jennings, M Murray.   

Abstract

When beagle dogs were infected with Trypanosoma brucei, a marked reduction in the plasma concentration of atrial natriuretic factor (ANF) occurred in the terminal stage of the disease during weeks 3 and 4. At the same time there was an increase in plasma renin activity (PRA) after infection. Ultrastructural studies of the atria of these dogs demonstrated a reduction in ANF granules. The changes in ANF and PRA occurred in association with severe pancarditis and the development of heart failure. By impairing the ability of the heart and kidneys to regulate blood volume, the alterations in ANF and PRA could be involved in the pathogenesis of heart failure in T. brucei-infected dogs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438145     DOI: 10.1007/bf00936451

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  10 in total

1.  Effects of atrial natriuretic peptide in the canine coronary circulation.

Authors:  R J Bache; X Z Dai; J S Schwartz; D G Chen
Journal:  Circ Res       Date:  1988-01       Impact factor: 17.367

2.  Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarction.

Authors:  R E Mendez; J M Pfeffer; F V Ortola; K D Bloch; S Anderson; J G Seidman; B M Brenner
Journal:  Am J Physiol       Date:  1987-12

3.  Physiology of the renal baroreceptor mechanism of renin release and its role in congestive heart failure.

Authors:  H Kirchheim; H Ehmke; P Persson
Journal:  Am J Cardiol       Date:  1988-09-09       Impact factor: 2.778

4.  The pathogenesis of experimentally induced Trypanosoma brucei infection in the dog. I. Tissue and organ damage.

Authors:  W I Morrison; M Murray; P D Sayer; J M Preston
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

5.  A microassay for active and total renin concentration in human plasma based on antibody trapping.

Authors:  J A Millar; B J Leckie; J J Morton; J Jordan; M Tree
Journal:  Clin Chim Acta       Date:  1980-02-14       Impact factor: 3.786

6.  Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods.

Authors:  A M Richards; G Tonolo; G D McIntyre; B J Leckie; J I Robertson
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

7.  Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption.

Authors:  P J Harris; D Thomas; T O Morgan
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

8.  Effects of endogenous atrial natriuretic peptide released by rapid atrial pacing in dogs.

Authors:  K P Walsh; T D Williams; R Canepa-Anson; E Pitts; S L Lightman; R Sutton
Journal:  Am J Physiol       Date:  1987-10

9.  ANF in experimental congestive heart failure.

Authors:  M Cantin; G Thibault; J F Ding; J Gutkowska; R Garcia; G Jasmin; P Hamet; J Genest
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

10.  Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans.

Authors:  W Oelkers; S Kleiner; V Bähr
Journal:  Hypertension       Date:  1988-10       Impact factor: 10.190

  10 in total
  8 in total

Review 1.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

2.  Oligopeptidases B from Trypanossoma cruzi and Trypanossoma brucei inhibit inflammatory pain in mice by targeting serotoninergic receptors.

Authors:  Rafaela Quintanilha Abrahão; Adriano Cardoso Franciosi; Douglas Andrade; Luiz Juliano; Maria Aparecida Juliano; Renata Giorgi; Camila Squarzoni Dale
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

3.  Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity.

Authors:  R E Morty; J D Lonsdale-Eccles; R Mentele; E A Auerswald; T H Coetzer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Oligopeptidase B deficient mutants of Leishmania major.

Authors:  Jane C Munday; Karen McLuskey; Elaine Brown; Graham H Coombs; Jeremy C Mottram
Journal:  Mol Biochem Parasitol       Date:  2010-09-29       Impact factor: 1.759

5.  Crystal structure of Leishmania major oligopeptidase B gives insight into the enzymatic properties of a trypanosomatid virulence factor.

Authors:  Karen McLuskey; Neil G Paterson; Nicholas D Bland; Neil W Isaacs; Jeremy C Mottram
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

6.  Expression, purification and preliminary crystallographic analysis of oligopeptidase B from Trypanosoma brucei.

Authors:  Dean Rea; Carole Hazell; Norma W Andrews; Rory E Morty; Vilmos Fülöp
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-07-25

Review 7.  Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.

Authors:  I M D Bastos; F N Motta; P Grellier; J M Santana
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

8.  Prolyl Oligopeptidase From Leishmania infantum: Biochemical Characterization and Involvement in Macrophage Infection.

Authors:  Camila Lasse; Clênia S Azevedo; Carla N de Araújo; Flávia N Motta; Milene A Andrade; Amanda Pereira Rocha; Iracyara Sampaio; Sébastien Charneau; Marc Gèze; Philippe Grellier; Jaime M Santana; Izabela M D Bastos
Journal:  Front Microbiol       Date:  2020-05-28       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.